AZN: AstraZeneca PLC - American Depositary Shares

AZN News

• 14:15 AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results
• 16:37 AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin
• 16:00 Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.07%
• 15:13 MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate
• 13:21 Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line?
• 16:33 Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data - Regeneron Pharmaceuticals (NASDAQ:REGN)
• 14:28 Factbox-Top pharma companies work to launch first weight-loss pill
• 11:22 Monopar Therapeutics stock initiated with Buy rating at H.C. Wainwright
• 19:00 Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?
• 17:19 What's Going On With BeOne Medicines Stock Monday? - Royalty Pharma (NASDAQ:RPRX), BeOne Medicines (NASDAQ:ONC), Amgen (NASDAQ:AMGN)
• 16:55 UK Drug Pricing Talks Collapse, Drugmakers Reject Offer Citing 'Uncompetitive' System - AstraZeneca (NASDAQ:AZN), Novartis (NYSE:NVS)
• 16:00 Sweden stocks higher at close of trade; OMX Stockholm 30 up 1.62%
• 12:43 ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth
• 12:27 Piper Sandler raises Ionis Pharmaceuticals stock price target on FDA approval
• 09:04 J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs - AstraZeneca (NASDAQ:AZN), Biogen (NASDAQ:BIIB)
• 00:52 Johnson & Johnson Stock (JNJ) Sickens Despite U.S. Manufacturing Pledge to Beat Tariffs - TipRanks.com
• 17:39 Ionis Pharmaceuticals stock steady as BMO maintains Market Perform rating
• 11:00 Hartford International Equity Fund Q2 2025 Commentary
• 16:15 What's Going On With IonQ Stock Wednesday? - IonQ (NYSE:IONQ)
• 16:00 Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.17%
• 13:50 Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
• 10:25 BTIG raises Tempus AI stock price target to $85 on strong Q2 growth
• 06:13 Hutchmed completes enrollment in lung cancer combination therapy trial
• 05:04 Zelluna ASA Q2 2025 slides: TCR-NK platform advances amid high cash burn